<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565643</url>
  </required_header>
  <id_info>
    <org_study_id>IRB No. 07023</org_study_id>
    <secondary_id>MO1RR10710</secondary_id>
    <nct_id>NCT00565643</nct_id>
  </id_info>
  <brief_title>Seprafilm® Adhesion Barrier and Cesarean Delivery</brief_title>
  <official_title>A Multicenter, Randomized, Controlled Trial of Seprafilm® Adhesion Barrier to Reduce Adhesion Formation Following Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Winthrop University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lehigh Valley Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Winthrop University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicenter, randomized, controlled, single blinded study to evaluate the effectiveness of
      Seprafilm® Adhesion Barrier in reducing adhesion formation in cesarean deliveries. Primary
      outcome will be measurement of the extent and severity of adhesions at the time of subsequent
      cesarean delivery. Secondary outcomes will include measures of safety, operative times (ex.,
      incision-delivery; total operative time).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients presenting to labor and delivery for delivery will be screened for eligibility. If a
      patient meets the inclusion and exclusion criteria, she will be offered enrollment in the
      study. After the project and informed consent are reviewed with the patient and all questions
      are answered, she will be asked to sign the informed consent. At this point, she will be
      considered a candidate for randomization.

      If the patient subsequently undergoes a cesarean delivery, she will be randomized to either:

        1. Group A - Placement of Seprafilm® prior to abdominal closure

        2. Group B - Routine closure without placement of Seprafilm® The chances of being assigned
           to either group will be equal (i.e., 1:1 randomization). The patient will be blinded
           with regard to Seprafilm placement.

      The investigators will collect additional data about the patient, her antepartum course,
      intra-operative events, and post-operative course. There are no additional tests or
      procedures ordered or performed during the hospital stay as part of this protocol. Enrollment
      in this study is not expected to alter the patient's length of stay.

      The antepartum, operative, and post-operative care of the patient will as directed by the
      patient's physician and participating institutions's standard policies and procedures. This
      study in no way changes or directs the care the patient would receive, except with regard to
      the placement of Seprafilm® Adhesion Barrier.

      A short-term telephone follow-up will be conducted approximately 6-8 weeks following
      randomization to assess for immediate post-operative complications.

      If a patient becomes pregnant again and undergoes a repeat cesarean delivery at a
      participating institution, the location and severity of adhesions (if any) would be assessed
      at the time of repeat cesarean delivery. The investigators will extract additional data from
      the chart including operative times, blood loss, and complications. An evaluation of
      adhesions would conclude the patient's participation in the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Adhesions</measure>
    <time_frame>3 to 5 years</time_frame>
    <description>The Percentage of participants with one or more adhesions, regardless of the extent or severity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adhesion Score</measure>
    <time_frame>3 to 5 years</time_frame>
    <description>Adhesion score. Derived by assigning 1 point for filmy adhesion and 2 points for dense adhesions at each of 6 possible sites in the abdomen. Thus the score can range from 0 (i.e., no adhesions at any location) to 12 (dense adhesions at each site).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Hemoglobin</measure>
    <time_frame>1 to 5 years</time_frame>
    <description>Hemoglobin level following randomization delivery - used to determine if there was a difference in blood loss between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative White Blood Cell Count</measure>
    <time_frame>1 to 5 years</time_frame>
    <description>Post-operative White blood cell count following randomization delivery - used to determine if there was difference in immune response or infection between the groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-Operative Complications</measure>
    <time_frame>1 to 5 years</time_frame>
    <description>Percentage of patients experiencing any of the predefined post-operative complications following randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative Maximum Temperature Following Randomization</measure>
    <time_frame>1 to 5 years</time_frame>
    <description>Maximum temperature of patient, &gt;24 hours following randomization delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Times at Subsequent Delivery</measure>
    <time_frame>3 to 5 years</time_frame>
    <description>Amount of time spent at the time of the subsequent delivery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">753</enrollment>
  <condition>Adhesions</condition>
  <condition>Cesarean Section</condition>
  <condition>Delivery, Obstetric</condition>
  <arm_group>
    <arm_group_label>HA-CMC Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyaluronic Acid-Carboxymethylcellulose placed as an adhesion barrier</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine Closure Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Routine Closure without placement of an adhesion barrier</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>modified sodium hyaluronic acid and carboxymethylcellulose</intervention_name>
    <description>Adhesion barrier applied at the time of initial cesarean delivery</description>
    <arm_group_label>HA-CMC Group</arm_group_label>
    <other_name>Seprafilm Adhesion Barrier</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Routine abdominal closure without placement of adhesion barrier</description>
    <arm_group_label>Routine Closure Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women who are planning or have the potential to undergo cesarean delivery

          -  Age over 18

          -  Able to consent to study

        Exclusion Criteria:

          -  Planned tubal ligation

          -  Known allergy to hyaluronic acid

          -  Medical or other serious condition which will interfere with compliance and/or ability
             to complete study protocol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel G Kiefer, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lehigh Valley Health Network</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Stony Brook University Hospital</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2007</study_first_submitted>
  <study_first_submitted_qc>November 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2007</study_first_posted>
  <results_first_submitted>December 30, 2015</results_first_submitted>
  <results_first_submitted_qc>March 22, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 22, 2016</results_first_posted>
  <last_update_submitted>March 22, 2016</last_update_submitted>
  <last_update_submitted_qc>March 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Winthrop University Hospital</investigator_affiliation>
    <investigator_full_name>Daniel Kiefer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Adhesion</keyword>
  <keyword>Seprafilm</keyword>
  <keyword>Cesarean section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Carboxymethylcellulose Sodium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HA-CMC Group</title>
          <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of cesarean delivery</description>
        </group>
        <group group_id="P2">
          <title>Routine Closure Group</title>
          <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="380"/>
                <participants group_id="P2" count="373"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Data</title>
              <participants_list>
                <participants group_id="P1" count="380"/>
                <participants group_id="P2" count="373"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Primary Outcome (Subsequent Cesarean)</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
                <participants group_id="P2" count="92"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="380"/>
                <participants group_id="P2" count="373"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HA-CMC Group</title>
          <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of cesarean delivery</description>
        </group>
        <group group_id="B2">
          <title>Routine Closure Group</title>
          <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="380"/>
            <count group_id="B2" value="373"/>
            <count group_id="B3" value="753"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.4" spread="5.1"/>
                    <measurement group_id="B2" value="30.9" spread="5.3"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="380"/>
                    <measurement group_id="B2" value="373"/>
                    <measurement group_id="B3" value="753"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="380"/>
                    <measurement group_id="B2" value="373"/>
                    <measurement group_id="B3" value="753"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gravid</title>
          <units>pregnancies</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" lower_limit="1" upper_limit="20"/>
                    <measurement group_id="B2" value="2" lower_limit="1" upper_limit="11"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Parity</title>
          <units>pregnancies</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="B2" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age (weeks)</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.7" spread="1.9"/>
                    <measurement group_id="B2" value="38.1" spread="3.9"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI), kg/m^2</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.3" spread="6.6"/>
                    <measurement group_id="B2" value="33.2" spread="7.8"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title># of previous cesarean births</title>
          <units>births</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="B2" value="1" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative Hematocrit</title>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.8" spread="4.3"/>
                    <measurement group_id="B2" value="34.4" spread="5.0"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative White Blood cell count</title>
          <units>cells/mm^3</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.3" spread="3.4"/>
                    <measurement group_id="B2" value="10.7" spread="4.6"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Preoperative Maximum Temperature</title>
          <units>degrees Fahrenheit</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97.8" spread="1.0"/>
                    <measurement group_id="B2" value="97.9" spread="0.9"/>
                    <measurement group_id="B3" value="NA">The Totals are unable to be calculated because the analysis was not performed for the Total population and there are no means to calculate.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Adhesions</title>
        <description>The Percentage of participants with one or more adhesions, regardless of the extent or severity</description>
        <time_frame>3 to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HA-CMC Group</title>
            <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of cesarean delivery</description>
          </group>
          <group group_id="O2">
            <title>Routine Closure Group</title>
            <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Adhesions</title>
          <description>The Percentage of participants with one or more adhesions, regardless of the extent or severity</description>
          <units>percentage of patients with adhesions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.6"/>
                    <measurement group_id="O2" value="75.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative Hemoglobin</title>
        <description>Hemoglobin level following randomization delivery - used to determine if there was a difference in blood loss between the two groups</description>
        <time_frame>1 to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HA-CMC Group</title>
            <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of cesarean delivery</description>
          </group>
          <group group_id="O2">
            <title>Routine Closure Group</title>
            <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Hemoglobin</title>
          <description>Hemoglobin level following randomization delivery - used to determine if there was a difference in blood loss between the two groups</description>
          <units>% of blood that is red blood cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="373"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.9" spread="4.1"/>
                    <measurement group_id="O2" value="30.2" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Adhesion Score</title>
        <description>Adhesion score. Derived by assigning 1 point for filmy adhesion and 2 points for dense adhesions at each of 6 possible sites in the abdomen. Thus the score can range from 0 (i.e., no adhesions at any location) to 12 (dense adhesions at each site).</description>
        <time_frame>3 to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HA-CMC Group</title>
            <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of initial cesarean delivery</description>
          </group>
          <group group_id="O2">
            <title>Routine Closure Group</title>
            <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
          </group>
        </group_list>
        <measure>
          <title>Adhesion Score</title>
          <description>Adhesion score. Derived by assigning 1 point for filmy adhesion and 2 points for dense adhesions at each of 6 possible sites in the abdomen. Thus the score can range from 0 (i.e., no adhesions at any location) to 12 (dense adhesions at each site).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative White Blood Cell Count</title>
        <description>Post-operative White blood cell count following randomization delivery - used to determine if there was difference in immune response or infection between the groups</description>
        <time_frame>1 to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HA-CMC Group</title>
            <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of initial cesarean delivery</description>
          </group>
          <group group_id="O2">
            <title>Routine Closure Group</title>
            <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative White Blood Cell Count</title>
          <description>Post-operative White blood cell count following randomization delivery - used to determine if there was difference in immune response or infection between the groups</description>
          <units>cells/mm^3</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="373"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" spread="6.4"/>
                    <measurement group_id="O2" value="11.0" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-Operative Complications</title>
        <description>Percentage of patients experiencing any of the predefined post-operative complications following randomization</description>
        <time_frame>1 to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HA-CMC Group</title>
            <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of initial cesarean delivery</description>
          </group>
          <group group_id="O2">
            <title>Routine Closure Group</title>
            <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
          </group>
        </group_list>
        <measure>
          <title>Post-Operative Complications</title>
          <description>Percentage of patients experiencing any of the predefined post-operative complications following randomization</description>
          <units>% of patients experiencing complication</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="373"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any complication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3"/>
                    <measurement group_id="O2" value="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5"/>
                    <measurement group_id="O2" value="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ileus or bowel obstruction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any wound complication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1"/>
                    <measurement group_id="O2" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Venous thromboembolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Readmission (&lt;=6 weeks postpartum)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                    <measurement group_id="O2" value="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative Maximum Temperature Following Randomization</title>
        <description>Maximum temperature of patient, &gt;24 hours following randomization delivery</description>
        <time_frame>1 to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HA-CMC Group</title>
            <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of initial cesarean delivery</description>
          </group>
          <group group_id="O2">
            <title>Routine Closure Group</title>
            <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Maximum Temperature Following Randomization</title>
          <description>Maximum temperature of patient, &gt;24 hours following randomization delivery</description>
          <units>degrees Fahrenheit</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="373"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.2" spread="1.0"/>
                    <measurement group_id="O2" value="98.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Times at Subsequent Delivery</title>
        <description>Amount of time spent at the time of the subsequent delivery</description>
        <time_frame>3 to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HA-CMC Group</title>
            <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of initial cesarean delivery</description>
          </group>
          <group group_id="O2">
            <title>Routine Closure Group</title>
            <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Times at Subsequent Delivery</title>
          <description>Amount of time spent at the time of the subsequent delivery</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Skin-to-delivery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="3" upper_limit="70"/>
                    <measurement group_id="O2" value="13" lower_limit="4" upper_limit="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total operative time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" lower_limit="23" upper_limit="175"/>
                    <measurement group_id="O2" value="54" lower_limit="26" upper_limit="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From time of enrollment through 8 weeks following randomization</time_frame>
      <group_list>
        <group group_id="E1">
          <title>HA-CMC Group</title>
          <description>modified sodium hyaluronic acid and carboxymethylcellulose (Seprafilm Adhesion Barrier): Adhesion barrier applied at the time of cesarean delivery</description>
        </group>
        <group group_id="E2">
          <title>Routine Closure Group</title>
          <description>Placebo: Routine abdominal closure without placement of adhesion barrier</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="380"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Readmission for Intra-abdominal complication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="380"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Readmission for Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="380"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Readmission for Central nervous system problem</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="380"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Readmission for obstetrical complications</sub_title>
                <description>Delayed Postpartum hemorrhage</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="380"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="380"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Daniel Kiefer</name_or_title>
      <organization>Lehigh Valley Health Network</organization>
      <phone>484-664-7521</phone>
      <email>daniel_g.kiefer@lvhn.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

